These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR, Lee WJ, Huang MT, Lin HH. Hepatogastroenterology; 2002 Feb; 49(46):1157-60. PubMed ID: 12143226 [Abstract] [Full Text] [Related]
6. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M. Cancer; 2004 Aug 15; 101(4):803-9. PubMed ID: 15305413 [Abstract] [Full Text] [Related]
7. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K. Anticancer Res; 2000 Aug 15; 20(3B):2177-80. PubMed ID: 10928173 [Abstract] [Full Text] [Related]
8. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Park IJ, Choi GS, Lim KH, Kang BM, Jun SH. Ann Surg Oncol; 2009 Nov 15; 16(11):3087-93. PubMed ID: 19629600 [Abstract] [Full Text] [Related]
10. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS. J Surg Res; 2010 Oct 15; 163(2):e45-50. PubMed ID: 20638687 [Abstract] [Full Text] [Related]
11. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S. Lung Cancer; 2007 Dec 15; 58(3):369-75. PubMed ID: 17697728 [Abstract] [Full Text] [Related]
12. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H. Ann Surg Oncol; 2008 Dec 15; 15(12):3433-9. PubMed ID: 18846401 [Abstract] [Full Text] [Related]
13. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis]. Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D. Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 15; 39(5):832-5. PubMed ID: 19024326 [Abstract] [Full Text] [Related]
14. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep 15; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
15. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H. Eur J Cardiothorac Surg; 2007 Sep 15; 32(3):440-4. PubMed ID: 17643308 [Abstract] [Full Text] [Related]
17. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T. Anticancer Res; 2001 Sep 15; 21(4B):3085-92. PubMed ID: 11712815 [Abstract] [Full Text] [Related]
18. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage? Kawachi R, Nakazato Y, Takei H, Koshi-ishi Y, Goya T. Interact Cardiovasc Thorac Surg; 2009 Aug 15; 9(2):199-202. PubMed ID: 19457896 [Abstract] [Full Text] [Related]
20. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma. Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL. Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]